AzTrials
AzTrials

Alveolar Ridge PreservationNCT04824235

Alveolar Ridge Preservation Using Amniotic Chorion Membrane

A study testing Amniotic Chorion Membrane and Bio-Oss xenograft and Amniotic Chorion Membrane only in people with Alveolar Ridge Preservation, run by Hams Hamed Abdelrahman at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

the present study is to compare the amniotic chorion membrane (ACM) alone versus the amniotic chorion membrane combined with xenograft for their efficacy in alveolar ridge preservation procedures regarding volumetric changes assessed by cone beam computed tomography (CBCT). Read more about this study

Who is it for?
Ages 20 to 45 years
Conditions the study is for
Alveolar Ridge Preservation
What is being tested?
Amniotic Chorion Membrane and Bio-Oss xenograft and Amniotic Chorion Membrane only
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteEgypt
Study dates
1 Dec 2020to 1 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients require extraction of a non-restorable (premolar or anterior tooth) located in the maxillary arch and needs implant restoration.
  • Type two sockets will be selected as revealed by Cone beam computed tomography(CBCT)
  • Absence of any systemic disease or drugs that contraindicate oral surgery using Modified Cornell Medical Index
  • Male and female within age range of 20-45 years.

Who cannot join

  • Smokers.
  • Patients with poor oral hygiene or non-compliant patients who are not willing to perform oral hygiene measures.
  • Pregnant and breast-feeding females.
  • Patients with acute peri-apical infection or sinus tract.
  • Vulnerable group of patients as handicapped patients, orphans,prisoners,etc

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Ain Shams Faculty of Dentistry

    Cairo

Other trials in Egypt

About this study

Official title: Alveolar Ridge Preservation Using Amniotic Chorion Membrane Alone or Combined With Xenograft (A Randomized Controlled Clinical Trial With Histological Evaluation)

the present study is to compare the amniotic chorion membrane (ACM) alone versus the amniotic chorion membrane combined with xenograft for their efficacy in alveolar ridge preservation procedures regarding volumetric changes assessed by cone beam computed tomography (CBCT).

Being tested
Amniotic Chorion Membrane and Bio-Oss xenograft, Amniotic Chorion Membrane only

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Amniotic Chorion Membrane and Bio-Oss xenograftOther

    Bioxclude Amniotic Chorion Membrane with xenograft (Bio-Oss) for ridge preservation

  • Amniotic Chorion Membrane onlyOther

    Bioxclude Amniotic Chorion Membrane only

Study groups in NCT04824235
Study groupRoleWhat they receive
Amnoitic Chorion Membrane and xenograftExperimentalextraction sockets where ridge preservation will be performed using Chorion Membrane with Xenograft
Receives: Other: Amniotic Chorion Membrane and Bio-Oss xenograft
Amnoitic Chorion Membrane onlyActive comparatorextraction sockets where ridge preservation will be performed using Chorion Membrane Alone
Receives: Other: Amniotic Chorion Membrane only

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Bucco-lingual bone width

    Bone width will be measured using bone caliper and radiographically

    Measured: at baseline, 1 months and 4 months

  2. Change in Corono-apical bone height

    Bone height using a pre-fabricated stent.

    Measured: at baseline, 1 months and 4 months

  3. total bone volume change

    It will be evaluated by the use of 3D scans of patient dental models

    Measured: at baseline, and 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Apr 2021
  2. Study start1 Dec 2020
  3. Primary completion1 Mar 2022
  4. Study completion1 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04824235
Sponsor's protocol ID
alveolar preservation
Status last verified
Jan 2025
First submitted
20 Mar 2021
Last updated
7 Jan 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Amniotic Chorion Membrane and Bio-Oss xenograft and Amniotic Chorion Membrane only in people with Alveolar Ridge Preservation, run by Hams Hamed Abdelrahman at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Bucco-lingual bone width (time frame: at baseline, 1 months and 4 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2025; AzTrials last refreshed its copy on 30 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in